ClearPoint Neuro (CLPT) EBT Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.50% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 11.26% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -8.83% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 5.78% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 103.34% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 74.66% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -27.02% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 54.33% |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn | -58.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -58.85% |
| Dec 31, 2025 | -43.63% |
| Sep 30, 2025 | -18.61% |
| Jun 30, 2025 | -32.30% |
| Mar 31, 2025 | -45.44% |
| Dec 31, 2024 | -15.13% |
| Sep 30, 2024 | -1.29% |
| Jun 30, 2024 | 38.40% |
| Mar 31, 2024 | 27.68% |
| Dec 31, 2023 | -5.30% |
| Sep 30, 2023 | -29.04% |
| Jun 30, 2023 | -66.03% |
| Mar 31, 2023 | -43.88% |
| Dec 31, 2022 | -7.79% |
| Sep 30, 2022 | 6.11% |
| Jun 30, 2022 | -17.77% |
| Mar 31, 2022 | -57.98% |
| Dec 31, 2021 | -67.92% |
| Sep 30, 2021 | -174.41% |
| Jun 30, 2021 | -118.12% |
| Mar 31, 2021 | -22.53% |
| Dec 31, 2020 | -49.93% |
| Sep 30, 2020 | -31.09% |
| Jun 30, 2020 | -7.73% |
| Mar 31, 2020 | -67.24% |
| Dec 31, 2019 | -35.32% |
| Sep 30, 2019 | 22.66% |
| Jun 30, 2019 | 17.62% |
| Mar 31, 2019 | 26.77% |
| Sep 30, 2016 | 13.08% |
| Jun 30, 2016 | 22.92% |
| Mar 31, 2016 | 29.90% |
| Sep 30, 2015 | 22.84% |
| Jun 30, 2015 | -19.83% |
| Mar 31, 2015 | -258.82% |
| Dec 31, 2014 | 2.79% |
| Sep 30, 2014 | -46.45% |
| Jun 30, 2014 | -8.45% |
| Mar 31, 2014 | 175.23% |
| Dec 31, 2013 | -441.60% |
| Sep 30, 2013 | -81.00% |
| Jun 30, 2013 | -300.61% |
| Mar 31, 2013 | 21.85% |
| Dec 31, 2012 | 71.24% |
| Sep 30, 2012 | 48.71% |
| Jun 30, 2012 | 72.25% |
| Mar 31, 2012 | -54.59% |